Moleculin Biotech, Inc. (MBRX) Reports Preclinical Data Showing Immune-Mediated Annamycin Activity

Moleculin reported preclinical data at AACR showing Annamycin’s antitumor activity in pancreatic models is partly mediated by CD8+ T cells. The finding is preclinical and Annamycin is not in pancreatic cancer trials.Material DetailsContext by AI AnalystThis is early-stage, hypothesis-generating dat…